ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,582, issued on March 18, was assigned to Sonivie Ltd. (Rosh HaAyin, Israel).
"Pulmonary hypertension treatment" was invented by Or Shabtay (Kibbutz Farod, Israel) and Dalit Shav (Glen Rock, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a therapeutically active agent usable in the treatment of pulmonary arterial hypertension (PAH), for use in the treatment of pulmonary arterial hypertension, as well as methods of treating PAH, said treatment and methods comprising administering such an active agent and effecting pulmonary artery denervation in the subject. In some aspects, a sub-therapeutically effective amount of the activ...